|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.445 HKD | +1.14% |
|
+39.06% | -55.05% |
CANbridge Pharmaceuticals Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 78.97 million compared to CNY 31.16 million a year ago. Net loss was CNY 483.48 million compared to CNY 1,077.01 million a year ago.
Basic loss per share from continuing operations was CNY 1.14 compared to CNY 11.43 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -55.05% | 24.15M | |
| +5.31% | 70.44B | |
| +10.97% | 8.94B | |
| -16.83% | 4.75B | |
| +43.48% | 4.5B | |
| +3.20% | 3.85B | |
| +18.82% | 2.38B | |
| -21.36% | 2.34B | |
| -29.67% | 2.2B | |
| +8.38% | 1.96B |
CANBRIDGE PHARMACEUTICALS INC. 
